{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:00:18Z","timestamp":1780470018827,"version":"3.54.1"},"reference-count":34,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>This study aims to develop a noninvasive CT-based radiogenomic framework to estimate imaging-associated biomarkers related to natural killer (NK) cell cytotoxicity in clear cell renal cell carcinoma (ccRCC). By linking imaging features to underlying molecular pathways, we address the limitations of invasive tissue sampling in assessing tumor heterogeneity and immune microenvironment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This study analyzed preoperative contrast-enhanced CT images from 143 patients with histologically confirmed ccRCC and transcriptomic data from 538 TCGA-KIRC tumor samples. Radiomic features (3,176 per tumor) were extracted using PyRadiomics from manually segmented 3D tumor volumes (validated by two radiologists), spanning seven feature classes and eight image filters. Feature selection included variance filtering, the Mann-Whitney U test for gene-expression stratification (high\/low groups), and redundancy removal via Pearson correlation analysis (|r| &amp;gt; 0.9), with AUC prioritization. An\n                      <jats:italic>\n                        L\n                        <jats:sub>1<\/jats:sub>\n                      <\/jats:italic>\n                      -penalized support vector machine model with leave-one-out cross-validation was developed to estimate expression levels of ICAM1 and RAET1E, two NK cytotoxicity-related biomarkers. External validation was performed using tissue microarrays and immunohistochemistry from 26 independent ccRCC cases. Differential gene expression was assessed using edgeR (FDR &amp;lt; 0.05, fold-change &amp;gt; 2) and survival analysis via Cox regression.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Transcriptomic analysis identified 835 imaging-associated genes enriched in immune-related pathways, with significant representation of the NK cell-mediated cytotoxicity pathway (KEGG,\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0&amp;lt;\u00a00.05). Among candidate genes, ICAM1 and RAET1E demonstrated the strongest radiogenomic associations (AUC\u00a0=\u00a075.7% and 67.3%, respectively). Immunohistochemistry confirmed increased ICAM1 and decreased RAET1E expression in ccRCC tissues. Higher ICAM1 and lower RAET1E expression were associated with advanced tumor stage and unfavorable survival outcomes. External validation of the\n                      <jats:italic>\n                        L\n                        <jats:sub>1<\/jats:sub>\n                      <\/jats:italic>\n                      -SVM model achieved predictive accuracies of 76.92% for ICAM1 and 73.08% for RAET1E, supporting the preliminary feasibility of this radiogenomic approach.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our findings suggest that CT-derived radiomic features may provide noninvasive imaging correlates of biomarkers related to NK cytotoxicity-in ccRCC. Radiogenomic analysis of ICAM1 and RAET1E may provide a complementary exploratory framework for noninvasive immune characterization and biomarker research in ccRCC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1773251","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:00:51Z","timestamp":1780466451000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["CT-based radiogenomic prediction of ICAM1 and RAET1E as biomarkers of NK cytotoxicity in clear cell renal cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinwei","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Radiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]},{"name":"Suzhou Key Laboratory for Integrated Stroke Prevention, Treatment, and Rehabilitation, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]},{"name":"Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[{"name":"Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xusheng","family":"Qian","sequence":"additional","affiliation":[{"name":"Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Radiology, the Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiliang","family":"Ji","sequence":"additional","affiliation":[{"name":"Suzhou Research Center of Medical School, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yakang","family":"Dai","sequence":"additional","affiliation":[{"name":"Suzhou Institute of Biomedical Engineering and Technology, Chinese Academy of Sciences","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, the Second Affiliated Hospital of Soochow University","place":["Suzhou, Jiangsu, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Radiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University","place":["Suzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-0499","article-title":"Tumor microenvironment dynamics in clear-cell renal cell carcinoma","volume":"9","author":"Vuong","year":"2019","journal-title":"Cancer Discov"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ccell.2021.10.001","article-title":"Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma","volume":"39","author":"Au","year":"2021","journal-title":"Cancer Cell"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan5951","article-title":"Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma","volume":"359","author":"Miao","year":"2018","journal-title":"Science"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4314","DOI":"10.1016\/j.cell.2021.06.020","article-title":"Single-cell sequencing links multiregional immune landscapes in ccRCC to therapy efficacy","volume":"184","author":"Krishna","year":"2021","journal-title":"Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00028","article-title":"Infection and immunodeficiency in patients with chronic kidney disease: current evidence and potential preventive strategies of Chinese medicine","volume":"12","author":"Yang","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00062","article-title":"Targeting the hepatocyte growth factor\/c-Met signaling pathway: new opportunities for kidney disease treatment","volume":"12","author":"Zou","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ccell.2022.09.011","article-title":"Technology meets TILs: deciphering T cell function in the -omics era","volume":"41","author":"Hudson","year":"2023","journal-title":"Cancer Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956679","article-title":"A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.18.20443","article-title":"Radiogenomics in clear cell renal cell carcinoma: machine learning-based high-dimensional quantitative CT texture analysis in predicting PBRM1 mutation status","volume":"212","author":"Kocak","year":"2019","journal-title":"AJR Am J Roentgenol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113205","article-title":"Intratumor heterogeneity and branched evolution revealed by multiregion sequencing","volume":"366","author":"Gerlinger","year":"2012","journal-title":"N Engl J Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054615","article-title":"Radiogenomics in renal cancer management: current evidence and future prospects","volume":"24","author":"Ferro","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1186\/s40001-024-01678-x","article-title":"DNA damage response alterations in clear cell renal cell carcinoma: clinical, molecular, and prognostic implications","volume":"29","author":"Xiao","year":"2024","journal-title":"Eur J Med Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1186\/s13244-025-01908-4","article-title":"From Radiomics to Radiogenomics: Decoding Renal Cell Carcinoma Biology for Precision Medicine-a narrative review","volume":"16","author":"He","year":"2025","journal-title":"Insights Imaging"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29222","article-title":"Non-invasive tumor grade evaluation in von Hippel-Lindau-associated clear cell renal cell carcinoma: a magnetic resonance imaging-based study","volume":"60","author":"Zahergivar","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13130663","article-title":"Radiogenomics of clear cell renal cell carcinoma: associations between CT imaging\u00a0features and mutations","volume":"270","author":"Karlo","year":"2014","journal-title":"Radiology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"7504","DOI":"10.21037\/qims-23-20","article-title":"An artificial intelligence-assisted diagnosis modeling software (AIMS) platform based on medical images and machine learning: a development and validation study","volume":"13","author":"Zhou","year":"2023","journal-title":"Quant Imaging Med Surg"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1198\/016214506000001383","article-title":"On L1-norm multiclass support vector machines: methodology and theory","volume":"102","author":"Wang","year":"2007","journal-title":"J Am Stat Assoc"},{"key":"B19","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40644-024-00768-7","article-title":"Radiomics predicts the prognosis of patients with clear cell renal cell carcinoma by reflecting tumor heterogeneity and microenvironment","volume":"24","author":"Wu","year":"2024","journal-title":"Cancer Imaging"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-020-0316-3","article-title":"The immunology of renal cell carcinoma","volume":"16","author":"Diaz-Montero","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816047","article-title":"Avelumab plus axitinib versus sunitinib for advanced renal-cell carcinoma","volume":"380","author":"Motzer","year":"2019","journal-title":"N Engl J Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12123888","article-title":"Cellular and molecular players in the tumor microenvironment of renal cell carcinoma","volume":"12","author":"Lasorsa","year":"2023","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.ccell.2021.02.013","article-title":"Progressive immune dysfunction with advancing disease stage in renal cell carcinoma","volume":"39","author":"Braun","year":"2021","journal-title":"Cancer Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e31816","article-title":"Identification of clear cell renal cell carcinoma subtypes by integrating radiomics and transcriptomics","volume":"10","author":"Gao","year":"2024","journal-title":"Heliyon"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2013.106","article-title":"Transmigrated neutrophils in the intestinal lumen engage ICAM-1 to regulate the epithelial barrier and neutrophil recruitment","volume":"7","author":"Sumagin","year":"2014","journal-title":"Mucosal Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1161\/CIRCRESAHA.118.313143","article-title":"YAP controls endothelial activation and vascular inflammation through TRAF6","volume":"123","author":"Lv","year":"2018","journal-title":"Circ Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15457","article-title":"Characterisation of RAET1E\/ULBP4 exon 4 and 3' untranslated region genetic architecture reveals further diversity and allelic polymorphism","volume":"103","author":"Cox","year":"2024","journal-title":"HLA"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104105","article-title":"Progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes","volume":"10","author":"Xu","year":"2025","journal-title":"ESMO Open"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054814","article-title":"MUC1 expression affects the immunoflogosis in renal cell carcinoma microenvironment through complement system activation and immune infiltrate modulation","volume":"24","author":"Lucarelli","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.14.13901","article-title":"Radiogenomics of clear cell renal cell carcinoma: preliminary findings of the relationship between CT imaging features and tumor molecular markers","volume":"205","author":"Shinagare","year":"2015","journal-title":"AJR Am J Roentgenol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"355.e11","DOI":"10.1016\/j.urolonc.2019.01.025","article-title":"Microvascular density, macrophages, and mast cells in human clear cell renal carcinoma with and without bevacizumab treatment","volume":"37","author":"Tamma","year":"2019","journal-title":"Urol Oncol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"S2090","DOI":"10.1016\/j.jare.2025.10.008","article-title":"Mitigation of renal tubular injury by SIRT6 may improve individual outcomes in diabetic kidney disease: potential mechanisms involving epigenetic repression of inflammatory responses","volume":"10","author":"Jin","year":"2025","journal-title":"J Adv Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/tox.24319","article-title":"Integrative analysis of bulk and single-cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma","volume":"39","author":"Xie","year":"2024","journal-title":"Environ Toxicol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.148.3.6878708","article-title":"A method of comparing the areas under receiver operating characteristic curves derived from the same cases","volume":"148","author":"Hanley","year":"1983","journal-title":"Radiology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T06:00:52Z","timestamp":1780466452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1773251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":34,"alternative-id":["10.3389\/fimmu.2026.1773251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1773251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"article-number":"1773251"}}